Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13810692 | 0.74 | MAPT (0.39) | — | |
| SCHEMBL13810689 | 0.74 | MAPT (0.39) | — | |
| SCHEMBL27764514 | 0.71 | ANPEP (0.41) | LTA4H | |
| SCHEMBL509933 | 0.69 | — | — | |
| SCHEMBL7647881 | 0.69 | — | — | |
| SCHEMBL8772703 | 0.68 | — | — | |
| SCHEMBL13810693 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL639872 | 0.67 | — | — | |
| SCHEMBL30098889 | 0.65 | — | — | |
| SCHEMBL4456152 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7541375-B2 | Azole derivatives and pharmaceutical compositions containing them | LABORATOIRES SERONO SA (CH) | 2009-06-02 | — | — | US | disclosed |
| US-20070293555-A1 | AZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293555-A1 | AZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | MAP3K1, MAP3K5, MAP3K2 | LTA4H 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.